Neurocrine wants to develop new obesity drugs. It’s making an acquisition to accelerate that move.
Soleno Therapeutics’ stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy the company.
Last updated: 2026-04-09 08:52:39 ET
Soleno Therapeutics’ stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy the company.
Rolling coverage of the latest economic and financial newsTrump claims Iran war ‘nearing completion’ and seeks to justify conflict in prime-time a...
President Trump defended the Iran war in a nationwide address on Wednesday and said the U.S.' military objectives are "nearing completion." The presid...
The US president's first televised address of the conflict with Iran did little to quell uneasy markets.
President Trump claimed in a White House address that the war on Iran was “nearing completion” but made no new announcements about the conflict.
The White House is trying to contain the consequences of a conflict that has sent gas prices soaring and soured feelings about the president and the economy.
President Donald Trump said Wednesday night that the U.S. military objectives in Iran are “nearing completion” of Operation Epic Fury and that he ...
President used speech to justify the war and offer a timeline for its completion, as he faces falling poll numbers and a global energy crisis‘We hav...
Trump says he expects the U.S. war with Iran to end within several weeks despite unrelenting attacks from both sides and Iran's iron grip on the Strai...
President says ‘little journey’ to Iran close to achieving US aims but offers few details on plan to wind down conflictMiddle East crisis – live...
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE